All Phenotypes Nampt<tm1Oleo> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Nampt^tm1Oleo/Nampt^tm1Oleo Tg(CD2-icre)4Kio/0	involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca	MGI:3818632
cn2	Nampt^tm1Oleo/Nampt^tm1Oleo Tg(Rho-icre)1Ck/0	involves: 129P2/OlaHsd * C57BL/6 * SJL	MGI:6383809
cn3	Nampt^tm1Oleo/Nampt^tm1Oleo Tg(OPN1LW-cre)4Yzl/0	involves: 129P2/OlaHsd * FVB/N	MGI:6383810

Allelic Composition	Nampt^tm1Oleo/Nampt^tm1Oleo Tg(CD2-icre)4Kio/0
Genetic Background	involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nampt^tm1Oleo mutation (1 available); any Nampt mutation (93 available)
Tg(CD2-icre)4Kio mutation (4 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

thymus hypoplasia ( J:141448 )

• thymic cell numbers are decreased 95% compared to in wild-type mice

decreased B cell number ( J:141448 )

• mice exhibit a near complete lack of peripheral B cells

decreased T cell number ( J:141448 )

• mice exhibit a near complete lack of peripheral T cells

decreased double-negative T cell number ( J:141448 )

• mice exhibit a near complete absence of double negative T cells compared to in wild-type mice

hematopoietic system

thymus hypoplasia ( J:141448 )

• thymic cell numbers are decreased 95% compared to in wild-type mice

decreased B cell number ( J:141448 )

• mice exhibit a near complete lack of peripheral B cells

decreased T cell number ( J:141448 )

• mice exhibit a near complete lack of peripheral T cells

decreased double-negative T cell number ( J:141448 )

• mice exhibit a near complete absence of double negative T cells compared to in wild-type mice

endocrine/exocrine glands

thymus hypoplasia ( J:141448 )

• thymic cell numbers are decreased 95% compared to in wild-type mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

vision/eye

optic nerve atrophy ( J:265592 )

• secondary with pallor by 6 weeks

abnormal retina morphology ( J:265592 )

• rounded and constricted with loss of cristae in the retinal mitochondria by 4 weeks

• cytoplasmic vacuoles containing degenerating organelles including ruptured mitochondria

abnormal photoreceptor inner segment morphology ( J:265592 )

• by 4 weeks

abnormal photoreceptor outer segment morphology ( J:265592 )

• by 4 weeks

retina photoreceptor degeneration ( J:265592 )

• by 6 weeks with massive atrophy of the neurosensory retina and vascular attenuation with pigment mottling

• however, nicotinamide mononucleotide treatment rescued regeneration

retina pigment epithelium atrophy ( J:265592 )

• by 6 weeks

thin retina outer nuclear layer ( J:265592 )

• progressive and almost completely absent by 6 weeks

decreased total retina thickness ( J:265592 )

• by 6 weeks

abnormal cone electrophysiology ( J:265592 )

• reduced b-waves amplitudes by 6 weeks of age

• reduced visual acuity by 6 weeks of age

• however, nicotinamide mononucleotide treatment rescued function

abnormal rod electrophysiology ( J:265592 )

• reduced a-waves amplitudes by 6 weeks of age

• however, nicotinamide mononucleotide treatment rescued function

cellular

abnormal mitochondrial morphology ( J:265592 )

• rounded and constricted with loss of cristae in the retinal mitochondria by 4 weeks

abnormal mitochondrial crista morphology ( J:265592 )

• loss of cristae in the retinal mitochondria by 4 weeks

nervous system

abnormal photoreceptor inner segment morphology ( J:265592 )

• by 4 weeks

abnormal photoreceptor outer segment morphology ( J:265592 )

• by 4 weeks

retina photoreceptor degeneration ( J:265592 )

• by 6 weeks with massive atrophy of the neurosensory retina and vascular attenuation with pigment mottling

• however, nicotinamide mononucleotide treatment rescued regeneration

optic nerve atrophy ( J:265592 )

• secondary with pallor by 6 weeks

pigmentation

retina pigment epithelium atrophy ( J:265592 )

• by 6 weeks

Allelic Composition	Nampt^tm1Oleo/Nampt^tm1Oleo Tg(OPN1LW-cre)4Yzl/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nampt^tm1Oleo mutation (1 available); any Nampt mutation (93 available)
Tg(OPN1LW-cre)4Yzl mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

vision/eye

retina cone cell degeneration ( J:265592 )

• at 3 weeks with massive atrophy of the neurosensory retina and vascular attenuation with pigment mottling

retina pigment epithelium atrophy ( J:265592 )

• at 3 weeks

abnormal cone electrophysiology ( J:265592 )

• photopic b-wave amplitude

• reduced visual acuity

• however, nicotinamide mononucleotide treatment rescued function

abnormal rod electrophysiology ( J:265592 )

• mild decline inn scotopic a- and b-wave amplitudes

• however, nicotinamide mononucleotide treatment rescued function

nervous system

retina cone cell degeneration ( J:265592 )

• at 3 weeks with massive atrophy of the neurosensory retina and vascular attenuation with pigment mottling

pigmentation

retina pigment epithelium atrophy ( J:265592 )

• at 3 weeks

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 09/30/2025 MGI 6.24